1-3 of 3
Tina Glisovic-Aplenc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting CD38 in T-ALL Upregulates the Targetable Polyamine Metabolism Pathway

Caroline Diorio, Tiffaney L. Vincent, Tori Fuller, Rawan Shraim, Tina Glisovic-Aplenc, Theresa Ryan, Kimberly Veliz, Haley Newman, Gerald Wertheim, Hamid Bassiri, Annette Vu, Michael Hogarty, Carl H June, Stephan A. Grupp, Sarah K Tasian, Richard Aplenc, Saar Gill, David T. Teachey
Journal: Blood
Blood (2022) 140 (Supplement 1): 10285–10286.
https://doi.org/10.1182/blood-2022-167893
Published: 2022
Journal Articles

Proteotranscriptomic Strategy to Discover Acute Myeloid Leukemia Immunotherapy Targets

Lusha Cao, Yang Xu, Tina Glisovic-Aplenc, Kevin Nestler, Saar Gill, Kathrin M. Bernt, Benjamin A Garcia, Hossein Fazelinia, Lingyu Guan, Yi Xing, Richard Aplenc
Journal: Blood
Blood (2022) 140 (Supplement 1): 3425–3426.
https://doi.org/10.1182/blood-2022-167378
Published: 2022
Journal Articles

Preclinical efficacy of daratumumab in T-cell acute lymphoblastic leukemia

Brief Report
Karen L. Bride, Tiffaney L. Vincent, Soo-Yeon Im, Richard Aplenc, David M. Barrett, William L. Carroll, Robin Carson, Yunfeng Dai, Meenakshi Devidas, Kimberly P. Dunsmore, Tori Fuller, Tina Glisovic-Aplenc, Terzah M. Horton, Stephen P. Hunger, Mignon L. Loh, Shannon L. Maude, Elizabeth A. Raetz, Stuart S. Winter, Stephan A. Grupp, Michelle L. Hermiston, Brent L. Wood, David T. Teachey
Journal: Blood
Blood (2018) 131 (9): 995–999.
https://doi.org/10.1182/blood-2017-07-794214
Published: 2018
Includes: Supplemental data